According to Fixygen, the pharmaceutical company “Spratli,” PJSC, will hold a virtual annual shareholders’ meeting on April 10, 2026. This is stated in the notice convening the meeting, published on the issuer’s official website on March 9.
The company is registered in Kyiv, with a charter capital of UAH 900,000; its CEO is Iryna Zolotko. According to Opendatabot, Iryna Zolotko is listed as the sole shareholder in the registry, holding a 100% stake.
The company’s latest available financial indicators in public registries look weak: revenue for 2025 amounted to 6.94 million UAH, net loss—2.33 million UAH, and total assets as of the end of 2025—6.08 million UAH.
https://www.fixygen.ua/news/20260407/spratli-provede-zbori-aktsioneriv-10-kvitnya.html
